PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neuroscience, Ospedale Policlinico San Martino, IRCCS, Genova, Italy.\', \'Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; Ospedale Policlinico San Martino, IRCCS, Genova, Italy.\', \'Ospedale Policlinico San Martino, IRCCS, Genova, Italy.\', \'Ospedale Policlinico San Martino, IRCCS, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.\', \'Ospedale Policlinico San Martino, IRCCS, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy. Electronic address: m.inglese@unige.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(20)30197-810.1016/j.msard.2020.102120
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 32315980
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all